Acknowledgements
SPENCER
The authors would like to acknowledge their gratitude to the patients who participated in this study, as well as their families and the investigating team at each participating site. This trial was sponsored by Shanghai Fosun Pharmaceutical Development Co., Ltd. Writing and editorial assistance were provided by Christopher Spencer, PhD and Emily Kelly of Parexel, funded by Shanghai Fosun Pharmaceutical Development Co., Ltd.